3 Min Read
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes fell on Tuesday, putting indexes on track to keep intact the market's recent trend of modest moves and low volume in the next-to-last trading day of the year. The Dow Jones industrial average was down 0.13 percent at 18,015.27, the S&P 500 was down 0.18 percent at 2,086.86 and the Nasdaq Composite was down 0.09 percent at 4,802.699.
** CIVEO CORP, $4.62, -44.14 pct
The company, which provides temporary housing for oilfield workers and miners, slashed its workforce on Monday and said revenue could fall by a third as slumping crude prices force oil producers to cut costs.
** AMERICAN REALTY CAPITAL PROPERTIES INC, $9.12, +7.55 pct
Activist investor Keith Meister's Corvex Management LP reported a 7.1 percent stake in the real estate investment trust. (1.usa.gov/1wwRWmL)
** NEURODERM LTD, $9.35, +51.29 pct
The pharma company said data from a mid-stage study suggested that a higher dose of its Parkinson's drug could provide an alternative to treatments that require surgery.
** TEKMIRA PHARMACEUTICALS CORP, $13.98, +0.87 pct
Shares of the Canadian drugmaker rose a day after a female healthcare worker in Glasgow was diagnosed with Ebola. Tekmira said last week that it would supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa next year.
The World Health Organization said on Monday that the number of people infected by Ebola in Liberia, Sierra Leone and Guinea - the worst affected by the outbreak - has passed 20,000, with more than 7,842 deaths in the epidemic so far.
** BG MEDICINES INC, $0.5206, +62.69 pct
The U.S. Food and Drug Administration approved the automated version of the company's BGM Galectin-3 test, which is used to measure galectin-3 protein levels in blood plasma. (Compiled by Manya Venkatesh in Bengaluru; Editing by Kirti Pandey)